Company & Sponsor Intelligence

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.

Request enterprise analysis →
Indexed trials7
Recruiting3
Completed2
Countries1

Therapeutic footprint

alzheimersautismbipolar_disorderepilepsyparkinsons

Indexed studies

NCT05946928EMERGENCE AGITATION After Premedication IN PAEDIATRIC MAGNETIC RESONANCE IMAGING: A RETROSPECTIVE COHORT STUDY
autism · Italy
COMPLETED
NCT06677632Targeting zDHHC Enzymes to Counteract Alzheimer's Disease
alzheimers · Italy
UNKNOWN
NCT07592650Applicability and Effectiveness of Remote Occupational Therapy
epilepsy · Italy
COMPLETED
NCT07592676Transition From Pediatric to Adult Care in Epilepsy
epilepsy · Italy
RECRUITING
NCT07732933Testing a New Gold Nanoparticle-Based Lithium Delivery Method for Bipolar Disorder in Laboratory Models
bipolar_disorder · Italy
NA
NCT06372587Next-Generation alzheImer'S Therapeutics
alzheimers · Italy
NA
NCT05752240Transcranial Direct Current Stimulation of the Primary Motor Cortex to Treat Levodopa-induced Dyskinesias
parkinsons · Italy
NA

Intelligence layer updated: 2026-10-11 23:31:09.606883+00:00

Enterprise intelligence

Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.

Request comparative intelligence →